Id |
Subject |
Object |
Predicate |
Lexical cue |
T65 |
0-23 |
Sentence |
denotes |
Testing of Human Plasma |
T66 |
24-174 |
Sentence |
denotes |
To evaluate the potential development of SARS-CoV-2 antibodies in the plasma donor community, samples of plasma pools of 6 donations each were tested. |
T67 |
175-309 |
Sentence |
denotes |
The use of pools enabled testing of a high amount of plasma donations for SARS-CoV-2 nAbs with the biosafety level-3 functional assay. |
T68 |
310-483 |
Sentence |
denotes |
As the mean SARS-CoV-2 µNT50 of plasma donations is rather high (approximately 1:230 [9]) even the nAbs of only 1 positive sample within a pool are detectable in this assay. |
T69 |
484-768 |
Sentence |
denotes |
Testing a total of 560 plasma pools of 6 donations each, in total reflective of 3360 plasma donations, from week 13 (ie, last week of March) until week 28 (ie, first week of July) 2020 revealed that most of these pools had SARS-CoV-2 µNT titers below the limit of detection (Table 1). |
T70 |
769-844 |
Sentence |
denotes |
The first pool with detectable nAbs to SARS-CoV-2 was collected in week 14. |
T71 |
845-907 |
Sentence |
denotes |
Further positive pools were found in weeks 15, 16, 24, and 28. |
T72 |
908-1120 |
Sentence |
denotes |
Up to 7% of the tested pools showed nAbs to SARS-CoV-2, which indicates that up to 1.17% of the plasma donors were positive for SARS-CoV-2 nAbs at a cumulative incidence of COVID-19 in Austria of 0.21% (Table 1). |
T73 |
1121-1129 |
Sentence |
denotes |
Table 1. |
T74 |
1131-1188 |
Sentence |
denotes |
SARS-CoV-2 Neutralizing Antibodies in Tested Plasma Pools |
T75 |
1189-1201 |
Sentence |
denotes |
Week in 2020 |
T76 |
1202-1239 |
Sentence |
denotes |
Parameter 13 14 15 16 20 24 28 |
T77 |
1240-1295 |
Sentence |
denotes |
Plasma pools ≥LOD, % 0.0 1.3 1.3 6.3 0.0 5.0 7.0 |
T78 |
1296-1339 |
Sentence |
denotes |
µNT50 of plasma pool titers ≥LOD, 1:X n.a. |
T79 |
1341-1371 |
Sentence |
denotes |
37 5 6, 18, 26, 34, 87 n.a. |
T80 |
1373-1410 |
Sentence |
denotes |
7, 10, 20, 22 4, 7, 8, 9, 12, 18, 24 |
T81 |
1411-1470 |
Sentence |
denotes |
Number of plasma pools tested 40 80 80 80 100 80 100 |
T82 |
1471-1564 |
Sentence |
denotes |
SARS-CoV-2 nAb positive plasma donors in Austria, % 0.00 0.21 0.21 1.04 0.00 0.83 1.17 |
T83 |
1565-1651 |
Sentence |
denotes |
Cumulative COVID-19 incidence in Austria, %a 0.10 0.14 0.16 0.17 0.18 0.19 0.21 |
T84 |
1652-1920 |
Sentence |
denotes |
Abbreviations: µNT50, neutralization titer for 50% of the wells; COVID-19, coronavirus disease 2019; LOD, limit of detection; n.a., not applicable; nAb, neutralizing antibody; PCR, polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. |
T85 |
1921-2050 |
Sentence |
denotes |
aSARS-CoV-2 PCR-positive individuals per 100 000 population in Austria are described as cumulative COVID-19 incidence in percent. |